glp 1 and semaglutide A Review on Semaglutide: An Oral Glucagon-Like Peptide Receptor Agonist in Management of Type 2 Diabetes Mellitus | Diabetes Therapy DietWorks GLP-1 Companion, Semaglutide Support,

Semaglutide targets GLP-1 only (~15% weight loss)

Talk to your healthcare provider about the why and when. You and your provider will want to decide when to stop tirzepatide (or taper) and when to start retatrutide

We offer physician-led talks and events to help you learn more about how to deal with stress through movement, mindfulness, and refocusing

Less commonly advertised are the side effects of these drugs, including nausea, vomiting, diarrhea, and constipation, and more serious risks like pancreatitis, thyroid tumors, and allergic reactions

In clinical trials, patients at this stage lost up to 8% of their body weight on average [1]